Detecting and Correcting Sample-by-Sample Scale Distortion in RNA Sequencing Data

Christopher Thron, Farhad Jafari · 2026

Read Detecting and Correcting Sample-by-Sample Scale Distortion in RNA Sequencing Data by Christopher Thron, Farhad Jafari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2605-22838.txt.

Introduction

Thron and Jafari detect a sample-by-sample distortion in RNA sequencing data, where measured gene expression shifts with expression level in ways standard normalization misses. Studying datasets from TCGA, SU2C, and GTEx, they found such biases throughout, and showed by simulation that they corrupt gene-gene correlations and group comparisons. Two new nonlinear transforms removed the biases, lowered sample variance, and raised test sensitivity and specificity by roughly three to five percent.

Catalog record

CREATORChristopher Thron, Farhad Jafari
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67826
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2605.22838

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Detecting and Correcting Sample-by-Sample Scale Distortion in RNA Sequencing Data Christopher Thron, Farhad Jafari Abstract RNA sequencing (RNA-seq) is the conventional genome-scale approach used to capture the expression levels of all detectable genes in a biological sample. This is now regularly used for population-based studies designed to identify genetic determinants of various diseases. Naturally, the accuracy of these tests should be verified and improved if possible. In this study, we aimed to detect and correct for expression level-dependent errors which vary from sample to sample, and are not corrected by conventional normalization techniques . We examined several RNA-seq datasets from the Cancer Genome Atlas (TCGA), Stand Up 2 Cancer (SU2C), and GTEx databases with various types of preprocessing. By applying local averaging, we found sample by sample expression-level dependent biases in all datasets studied. Using simulations, we show that these biases corrupt gene-gene correlation estimations and t t tests between subpopulations. To mitigate these biases, we introduce two different nonlinear transforms based on statistical considerations that correct these observed biases. We demonstrate that that these transforms effectively remove the observed per-sample biases, reduce sample-to-sample variance, and improve the characteristics of gene-gene correlation distributions. Using a novel simulation methodology that creates controlled differences between subpopulations, we show that these transforms reduce variability and increase sensitivity of two population tests. The improvements in sensitivity and specificity were of the order of 3-5% in most instances after the data was corrected for bias. Altogether, these results improve our capacity to understand gene-gene relationships, and may lead to novel ways to utilize the information derived from clinical tests. Keywords: RSEM (RNA Sequence by Expectation Maximization), TPM (Transcripts Per Million), FPKM (Fragments Per Kilobase of exon per Million), Local Leveling, PCA, ROC Curves, Populations. 1 Introduction Gathering gene expression data from clinical samples is no longer a technical hurdle, and RNA-seq data is now frequently conducted on biological samples from the clinical and laboratory settings. When considering the holistic profile of gene expression patterns, one can inform of perturbed activity in the cell or tumor models. This information is clinically relevant since dysregulated gene activity is what altogether drives the pathogenesis of the patient’s tumors [ 12 ] . The recognition of collective changes in tumor samples guides pre-clinical research by identifying novel signaling mechanisms and oncogenic processes. Further, this knowledge is purposed towards the development of biomarkers and precision therapies that may extend the survival of cancer patients. Justifiably there is exceptional value in gathering RNA-seq data from clinical specimens; however, quality issues remain due to sequencing platforms themselves or the downstream informatics approaches and data aggregation used to interpret such data. An extensive survey of the sequencing platforms is given in [ 7 ] . In current practice, gene expression levels are estimated based on RNA sequence (RNA-Seq) data obtained from populations of patients. RNA-seq data is generated by isolating RNA from a cell or tissue, converting it to complementary DNA (cDNA), preparing a sequencing library, and using a sequencing platform to convert to transcript counts [ 5 ] . The gene transcript raw counts for each sample are typically first corrected for fragmentation effects by dividing the raw counts for each transcript by the effective transcript length [ 5 ] . This takes into account the fact that a read can occur at multiple locations along the transcript, so the number of reads per gene will be proportional to the gene transcript length. These corrected counts are then rescaled by multiplying by an overall factor. The two most widely used rescalings are transcripts per million (TPM) and fragments per kilobase of exon per million (FPKM) [ 25 ] . In particular, TPM multiplies the corrected counts so that the resulting rescaled counts sum to 1 million. It is commonly recognized that TPM is more suitable than FPKM for cross-sample comparisons [ 25 ] . Several other rescalings have also been proposed [ 15 ] . Note that the only difference between these different rescalings is an overall multiplicative factor, which varies from sample to sample. The gold standard in gene expression analysis is arguably the paper of Wang et al. [ 21 ] (with more than 16,000 citations) where the authors highlight the strength of RNA sequence data over traditional micro-arrays, particularly in its ability to detect novel transcripts and measure gene expression levels more accurately. They already begin a discussion about biases inherent in such data that is introduced by library preparation steps and sequencing depth. Schurch et al. [ 18 ] investigate how different sequencing protocols (e.g. poly-A selection vs. rRNA depletion) can impact gene quantification, and they emphasize the need for standardized protocols. In particular, their conclusions are consistent with the fact that such standardized corrections/metrics do not exist. Robinson et al. [ 16 ] introduce DESeq method, which addresses biases related to depth and gene length using negative binomial distribution and provide a framework for differential expression analysis while accounting for over-dispersion in count data. Zhao et al [ 24 ] explore GC content bias, sequencing depth bias and the other biases, and present methods to mitigate these biases, including normalization and statistical approaches. Weiss et al [ 22 ] use DESeq and recommend sequencing strategies to minimize bias and improve the utility for various of RNA-Seq experiments. Nueda et al. [ 11 ] , Roberts et al. [ 14 ] , Soneson et al. [ 19 ] focus on the challenges of analyzing RNA-Seq data related to batch effects and sequencing platform differences and use various statistical approaches to account for these biases and improve the accuracy of differential gene expression analysis. Yip et al. [ 23 ] review the importance of correcting for biases and propose practical guidelines for addressing them during data processing. This brief summary and the literature cited with their extensive references purport the need for standardized methods to identify and deal with biases that are routinely seen in the sequencing data. In developing standard normalization methods to deal with biases, the works of (see [ 10 ] , [ 17 ] , [ 3 ] , [ 16 ] ) can be cited. Specifically the (2021) paper of Feng and Li [ 3 ] is particularly noteworthy. This paper incorporates the work of Robinson, McCarthy and Smyth [ 16 ] and a significant amount of literature of the previous decade. Feng and Li base their normalization on a set of "housekeeping genes" while at the same time questioning the existence of these housekeeping genes and their selection. They carry out pairwise normalization with respect to multiple references, selected from representative samples. Then the pairwise intermediates are integrated based on a linear model that adjusts the reference effects. Motivated by the notion of housekeeping genes and their statistical counterparts, they adopt regression methods and compare their results with existing tools on some standard datasets. Their conclusion suggests that their analysis (MUREN) adjusts the mode of differentiation toward zero, while preserving the skewness due to biological asymmetric differentiation. Their Fig. 1 summarizes workflow. While there is some overlap between their work and ours, their mathematical analysis of the bias and their use of linear regression and housekeeping genes is quite different from our estimation

Read the complete text